$ Value
$0
Shares
124,022
Price
$0
Filed
Oct 28
Insider
Name
GILLIS JONATHAN
Title
CAAO and PAO
CIK
0001709954
Roles
Transaction Details
Transaction Date
2025-10-27
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
124,022
Footnotes
Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date. | Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. | 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Filing Info
GILLIS JONATHAN's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-15 | MPLT | ▼ | $96K |
| 2026-02-05 | MPLT | A | $0 |
| 2026-02-05 | MPLT | A | $0 |
| 2026-01-27 | MPLT | F | $396K |
| 2025-10-27 | MPLT | A | $0 |
| 2025-10-27 | MPLT | A | $0 |
Other Insiders at MPLT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Pavlov George | $441K | — | 2026-02-20 |
| Garnett Timothy John | $253K | — | 2026-02-10 |
|
Kroeger Christopher A.
Chief Executive Officer
|
— | $521K | 2026-04-16 |
|
GILLIS JONATHAN
CAAO and PAO
|
— | $96K | 2026-04-15 |
|
Lillie James Woodruff
Chief Scientific Officer
|
— | $123K | 2026-04-16 |
|
Hanson Kristopher
General Counsel
|
— | $49K | 2026-04-16 |
| Malenka Robert C. | — | $1.6M | 2026-04-15 |
|
Foff Erin Pennock
Chief Medical Officer
|
— | $87K | 2026-04-16 |
|
Kreitzer Anatol
Chief Discovery Officer
|
— | $88K | 2026-04-15 |
|
Setia Vishwas
Chief Financial Officer
|
— | $79K | 2026-04-16 |